WANdisco is the world leader in Active Data Replication. Their patented technology enables the replication of continuously changing data to the cloud and on-premises data centers with guaranteed consistency, no downtime and no business disruption. WANdisco has an OEM with IBM as well as strategic partnerships with Amazon Web Services, Cisco, Google, HP Enterprise, Microsoft Azure and Oracle to resell their patented technologies. Their customers include many Fortune 1000 companies around the world who work with them to ensure their data can give them the real insight they need. Below is our interview with David Richards, CEO of WANdisco:
Q: David, you’ve recently announced your first contract in Healthcare sector; could you tell us something more?
A: Sadly, we can’t name many of our customers. But in this instance, a large US healthcare company which serves 50 million Americans in all 50 states needed to deploy business-critical strategic patient data across a new Big Data/Cloud infrastructure which has stringent requirements around continuous availability of the applications and data. Fusion was therefore selected as it was the only enterprise-level solution that could transfer the large volumes of continuously changing critical patient data to the Cloud without impacting its availability and consistency.
Q: Can you give us more insights into your products?
A: We are the only solution in the world which can move large volumes of continuously changing, transactional data to different storage environments with guaranteed data consistency and no downtime. Our products are underpinned by our Fusion technology which takes the Paxos algorithm, the foundation of distributed computing, to the next level. We also solve the eight fallacies of distributed computing – something computer science still says is impossible.
Q: What makes WANdisco a good choice?
A: We are the only solution in the world which can move continuously changing data to a different storage environment with guaranteed consistency, no downtime and no business disruption. This is what led to our OEM with IBM, where we are white labelled as IBM Big Replicate, and our partnerships with Amazon Web Services, Cisco, Google, HP Enterprise, Microsoft Azure and Oracle.
Q: What are your plans for next six months?
A: The investment thesis is simple.
If you believe that companies move key applications from “small data’ to ‘big data’ then they will need to continue to support the same stipulated regulations around data availability & reliability. What was a “minimal outage” in the small data world is a major outage in the big data world.We will continue to prove that we are the only solution to this problem in the best way possible: signing new customers.